Fig. 3

Predictive value of TASL expression on the immune signature of 20 cancer types. A-B AUC value of predicted immune score and TIL using TASL, PD-L1, PD-1, CTLA-4 expression, TMB, MSI and glycolysis score. C Spearman’s correlation between TASL expression and immune checkpoint gene expression, TMB, and MSI in 20 types of cancers in TCGA. D Differential expression of immune checkpoint genes in the TASL low and high expression groups of 20 types of cancers from TCGA (*P < 0.05; **P < 0.01; ***P < 0.001)